Haleon (HLN) Net Income towards Common Stockholders (2021 - 2023)

Haleon (HLN) recorded quarterly Net Income towards Common Stockholders of $453.0 million in Q4 2023, up 21.48% on a QoQ basis from $372.9 million in Q2 2023, and up 11.95% year-over-year from $404.7 million in Q4 2022.

Haleon (HLN) Net Income towards Common Stockholders (2021 - 2023) Analysis & Trends

Haleon has disclosed Net Income towards Common Stockholders across 3 years of filings, most recently posting $453.0 million for Q4 2023.

  • Quarterly Net Income towards Common Stockholders rose 11.95% year-over-year to $453.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2025 was $453.0 million (down 45.15% YoY) and the FY2025 annual result came in at $2.2 billion, up 19.24% from the prior year.
  • Net Income towards Common Stockholders climbed to $453.0 million in Q4 2023, from $372.9 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $1.5 billion in Q3 2022 and troughed at $372.9 million in Q2 2023.
  • A 3-year average of $669.3 million and a median of $464.3 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 52.5% — and 2023, when it climbed 11.95%.
  • Tracing HLN's Net Income towards Common Stockholders over 3 years: stood at $851.9 million in 2021, then sank by 52.5% to $404.7 million in 2022, then grew by 11.95% to $453.0 million in 2023.
  • Business Quant data shows HLN's Net Income towards Common Stockholders at $453.0 million in Q4 2023, $372.9 million in Q2 2023, and $475.7 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 Haleon 1.09 Bn -776.09 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 453.02 Mn
Jun 30, 2023 372.91 Mn
May 3, 2023 475.66 Mn
Dec 31, 2022 404.66 Mn
Sep 20, 2022 1.46 Bn
Dec 31, 2021 851.94 Mn